April 2005

 

  

ISPOR e-BULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

 

Please share these new ISPOR activities with your colleagues.

 

NEW THIS MONTH

**UPDATE**    ISPOR 10^th Annual International Meeting (New ISPOR SIG & Council Forums)

**NEW**    Bernie O’Brien Benefit Dinner

**NEW**    ISPOR Board of Directors Candidates (PLEASE VOTE: Deadline April 15, 2005)

**NEW**    Value in Health Vol. 8 No.1 (March/April 2005)

**NEW**    2005 ISPOR Award Recipients

**NEW**    ISPOR Task Force: Using "Real World" Data In Coverage And Reimbursement Decisions New Co-Chair

**NEW**    17 New Employment Positions At The ISPOR Website

**NEW**    Director, Program for Assessment of Technology in Health (PATH) Position Available at McMaster University

**NEW**    ISPOR Eighth Annual European Congress (On-line abstract submission began March 15, 2005)

**NEW**    ISPOR 2^nd Asia-Pacific Conference (Abstract On-line submission begins 1 July 2005)

**NEW**    Taiwan Chapter Is New ISPOR Local Chapter

 

 

ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Hot Topics

8.       Important Dates to Remember

8.       Asia Consortium and Local Chapter News

10.    Employment in Pharmacoeconomics and Outcomes Research

11.    Membership

 

1. PUBLICATIONS

Top

 

VALUE IN HEALTH

 

Value in Health: Volume 8, Issue 2, March/April 2005 is online and available this month at: http://www.ispor.org/valueinhealth_index.asp.  The following is the TABLE OF CONTENTS for Value in Health Volume 8, Issue 2, March/April 2005:

 

EDITORIALS

The Translation And Cultural Adaptation Of Patient Reported Outcome Measures

Stephen P McKenna PhD and Lynda C Doward MRes

Comments on the ISPOR Task Force Report on Translation and Adaptation of Outcomes Measures:  Guidelines and the Need for More Research

William R. Lenderking PhD

 

ISPOR SCIENTIFIC TASK FORCE REPORT

Principles Of Good Practice For The Translation And Cultural Adaptation Process For Patient Reported Outcomes (PRO) Measures: Report Of The ISPOR Task Force For Translation And Cultural Adaptation

Diane Wild MSc, Alyson Grove MSc, Mona Martin MPA, MPA, Sonya Eremenco MA, Sandra Ford, Aneesa Verjee-Lorenz, MSc, Pennifer Erikson, PhD

 

EMPIRICAL

Cost-Effectiveness Of Rhuepo For Reducing RBC Transfusions In Critically Ill Patients

             Robert MacLaren PharmD, Patrick W. Sullivan PhD

 

Using Multiple Anchor- And Distribution-Based Estimates To Evaluate Clinically Meaningful Change On The Functional Assessment Of Cancer Therapy-Biologic Response Modifiers (FACT - BRM) Instrument

Kathleen J. Yost PhD, Mark V. Sorensen PhD, Elizabeth A. Hahn MA, G. Alastair Glendenning MSc, Ari Gnanasakthy MBA, MSc, David Cella PhD

 

Cardiac Resynchronization Therapy (CRT) In Heart Failure – A Model To Assess The Economic Value Of This New Medical Technology       

Kurt Banz MSc on behalf of the Eucomed CRT Steering Committee

 

Excess Mortality, Length of Stay, and Costs Associated with Serious Fungal Infections Among Elderly Cancer Patients: Findings from Linked Seer-Medicare Data

Joseph Menzin PhD, Kathleen M. Lang PhD, Mark Friedman MD, Deirdre Dixon, Jeno P. Marton MD, Jerome Wilson PhD

 

THe Economic Burden Of Anemia In Cancer Patients Receiving Chemotherapy

Gary H. Lyman MD, MPH, Earnst R. Berndt PhD, Joel D. Kallich PhD, M. Haim Erder PhD, William H. Crown PhD, Stacey R. Long MS, Howard Lee MD, Xue Song PhD,

Stan N. Finkelstein MD

 

METHODOLOGY

            Validation Of The Restless Legs Syndrome Quality Of Life Questionnaire

Linda Abetz MA, Susan M. Vallow BSc, MA, MBA, Jeff Kirsch PhD, MRPhS, Richard P. Allen PhD, Tinna Washburn BA, Christopher J. Earley MD, PhD

 

Comparing The Discriminative Validity Of Two Generic And One Disease-Specific Health-Related Quality Of Life Measures In A Sample Of Patients With Dry Eye

Krithika Rajagopalan PhD, Linda Abetz MA, Polyxane Mertzanis MPH, Derek Espindle MA, Carolyn Begley OD, MS, Robin Chalmers OD, Barbara Caffery OD, MS, Christopher Snyder OD, MS, J. Daniel Nelson MD, Trefford Simpson PhD, Timothy Edrington OD, MS  

 

CORRESPONDENCE

 

Comments to the Editor on ‘Outcomes and Costs of Risperidone vs. Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: a Markov Model’

Jerry D. Clewell PharmD, MBA, BCPS and Robert W. Baker MD

 

ISPOR CONNECTIONS

 

ISPOR CONNECTIONS: Volume 11, Issue 2, March/April 2005 will be available to the public later this month at: http://www.ispor.org/news/index_new.asp. 

 

Featured in this issue: 

        The $64,000 Question: What Are We Willing To Pay for A QALY

        Cam Donaldson MD, University of Newcastle upon Tyne, Newcastle upon Tyne, UK

        (The second part of a 3-part series taken from the Third Plenary Session, Wednesday May    

        13, 2004, at the ISPOR 9^TH Annual International Meeting, Arlington, VA, USA)

 

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS

 

"RTI Health Solutions clients appreciated receiving the ISPOR Book of Terms. They found it to be a valuable resource." Graham Dyck, Director, Marketing and Business Development, RTI Health Solutions

 

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp.  Contact Stephen Priori at spriori@ispor.org for information on orders over 1000. 

 

  

2. ISPOR MEETINGS AND CONGRESSES

Top

   

**UPDATE** ISPOR 10TH ANNUAL INTERNATIONAL MEETING

     May 15-18, 2005, Marriott Wardman Park Hotel, Washington, DC, USA

 

Over 600 contributed presentations (a 20% increase) at the ISPOR 10^th Annual International Meeting!!!!! 26 workshops, 8 issues panels, 64 podium, and 520 contributed poster presentations.

 

For program information, go to: http://www.ispor.org/meetings/washington0505/index.asp

 

Early Registration Deadline: April 19, 2005

 

HOTEL RESERVATIONS, online reservations and additional information:

http://www.ispor.org/meetings/washington0505/hotel.asp

 

MEETING AT A GLANCE

http://www.ispor.org/meetings/washington0505/index.asp

 

EXHIBIT SPACE, contract available online at:

https://www.ispor.org/Exhibit_Sponsor/ExhibitorOpportunities.aspx?event=2

 

SPONSORSHIP Opportunities are available, for more information go to:

https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=2

 

PROFESSIONAL RECRUITMENT CENTER (PRAP) Advertise employment opportunities:

http://www.ispor.org/prap.asp

 

PRE-MEETING SYMPOSIUM: Evolution and Innovation of Pharmaceutical Technology: Implications for US Medicare Modernization Act co-sponsored by ISPOR and the PhRMA Health Outcomes Committee

Sunday, May 15, 2005, 5:00-7:00PM

Marriott Wardman Park Hotel, Washington DC, USA (Prior to the ISPOR 10^th Annual International Meeting)

 

SYMPOSIUM: Methodological Issues in the Analysis of Health Care Databases sponsored by: IMS Health

Monday, May 16, 2005, 1:00-2:00PM

Marriott Wardman Park Hotel, Washington DC, USA (During the ISPOR 10^th Annual International Meeting)

 

**NEW**BERNIE O’BRIEN BENEFIT DINNER

     

      SUNDAY, MAY 15, 2005 7:30 PM – 10:30 PM

      We invite you to an evening of fine food and beverages as we explore the lighter side of ISPOR members and friends. This event honors the fun-loving spirit of Bernie J. O'Brien MSc, PhD, and supports the Bernie J. O'Brien New Investigator Award Endowment Fund and the Emma and Lucy O'Brien Trust Fund.

 

      For more information and to register for this, go to: http://www.ispor.org/meetings/washington0505/OBrien_benefit.asp

 

JOIN US IN CELEBRATING THE ISPOR 10th ANNIVERSARY!!

 

ISPOR celebrates its 10-Year Anniversary though out the 10th Annual International Meeting!  The schedule of celebratory events is as follows:

 

MONDAY, MAY 16

8:00-8:30 AM ISPOR: 10 YEARS – "PAST, PRESENT AND FUTURE"

 

12:30–2:00 PM ISPOR 10 YEARS CELEBRATION CAKE CUTTING CEREMONY

 

6:00-8:00PM ISPOR 10th ANNIVERSARY CELEBRATION AND GIFTS

 

TUESDAY, MAY 17

10:45-11:15 AM 10 YEAR MEMBERS' RECOGNITION

 

12:30PM–1:30PM ISPOR 10 YEARS CELEBRATION

 

5:00-7:00PM ISPOR 10th ANNIVERSARY CELEBRATION AND TOASTS   

 

7:30- 10:30 PM ISPOR 10^th ANNIVERSARY PARTY AT THE Sequoia Restaurant on the Potomac River, open bar & food, DJ and dance floor, door prizes, quiz games, transportation to/from the Marriott Wardman Park Hotel, Only $50 USD

Register online: http://www.ispor.org/meetings/washington0505/anniv_party.asp

 

WEDNESDAY, MAY 18

10:30- 11:00AM ISPOR 10 YEARS PAST PRESIDENTS' RECOGNITION

 

**NEW** ISPOR EIGTH ANNUAL EUROPEAN CONGRESS

      6-8 November 2005 Palazzo Degli Affari, Florence , Italy

     

      Online Abstract Submission begins March 15, 2005.

 

      For more details, go to: http://www.ispor.org/congresses/italy1105/index.asp

 

 

 

3. EDUCATION ACTIVITIES

Top

           

ISPOR SHORT COURSES

Saturday, May 14^th & Sunday May 15^th, 2005 - Prior to the ISPOR 10^th Annual International Meeting

 

For short course descriptions and faculty information go to:

·       Saturday, May 14th: http://www.ispor.org/meetings/washington0505/sc14.asp

·       Sunday, May 15th: http://www.ispor.org/meetings/washington0505/sc15.asp

 

 

Pharmacoeconomics Courses:

·       Pharmacoeconomics for Decision-makers – Saturday Full Day Course (8:00am-5:00pm)

·       Elements of Pharmaceutical Pricing – Sunday Morning Course (8:00am-12:00pm)

 

Clinical Assessment Courses:

·       Retrospective Database Analysis: Econometric Methods – Sunday Full Day Course (8:00am-5:00pm)

·       Meta-Analysis and Systematic Literature Review – Sunday Morning Course (8:00am-12:00pm)

 

Modeling Courses:

·       Bayesian Analysis: Overview – Saturday Morning Course (8:00am-12:00pm)

·       Bayesian Analysis: Applications – Saturday Afternoon Course (1:00pm-5:00pm)

·       Modeling: Structure & Design of Model – Sunday Full Day Course (8:00am-5:00pm)

·       Discrete Event Simulation for Economic Analyses - Sunday Afternoon Course (1:00pm-5:00pm)

·       Introduction to Decision Analysis – Saturday Afternoon Course (1:00pm-5:00pm)

 

Quality of Life/Patient-reported Outcomes Courses:

·       Introduction to Quality of Life/Patient-Reported Outcomes – Saturday Afternoon Course (1:00pm-5:00pm)

·       Old and New Utility Measures in Health Economics and Outcomes Research – Sunday Morning Course (8:00am-12:00pm)

·       Advanced Quantitative Methods for Quality of Life/Patient-reported Outcomes Research – Sunday Afternoon Course (1:00pm-5:00pm)

 

Economic Analysis Courses:

·       Financial Impact / Cost of Illness – Saturday Afternoon Course (1:00pm-5:00pm)

·       Cost Estimation: Finding and Extracting Cost Data – Sunday Morning Course (8:00am-12:00pm)

·       Statistical Considerations in Economic Evaluations – Sunday Afternoon Course (1:00pm-5:00pm)

 

ISPOR Distance Learning Program Modules

http://www.ispor.org/distancelearning/index.asp

 

**NEW** Pharmacoeconomic Evaluations and Methods

·         Stratified Claims for Cost-Effectiveness

·         Summarizing Clinical Data and Meta-Analysis

 

**NEW** Pharmacoeconomics in Drug Development, Reimbursement and Marketing

·         Pharmacoeconomics and in Market Entry and Market Support

·         Pharmacoeconomics and Drug Product Valuation

 

**NEW** Cost-Effectiveness Analysis

·         Ranking and Thresholds in Cost-Effectiveness Claims

·         Monitoring and Validating Cost-Effectiveness Claims

     

**NEW** Guidelines and Reference Standards

·         Guidelines in Europe: The NICE Technical Guidance and Its Implications

·         Guidelines in Europe: The Scottish Medicines Consortium’ Guidelines

 

The following module topics are currently available (total of 40 modules):

·      Pharmacoeconomics

·      Pharmacoeconomic Evaluations &  Methods

·      Cost-Effectiveness Analysis

·      Cost-Benefit Analysis

·      Cost-Utility Analysis

·      Patient-Reported Outcomes (Utilities, Health-Related Quality Of Life, Treatment Satisfaction, Treatment Adherence, Patient Preferences)

·      Study Design in Pharmacoeconomics

·      Guidelines and Reference Standards

·      Pharmacoeconomics in Drug Development, Reimbursement and Marketing

 

 

4. STUDENT NEWS

Top

 

Visit ISPOR Internship- Professional Recruitment Assistance Program (I-PRAP)

http://www.ispor.org/iprap/index.asp

 

STUDENTS have the opportunity to search for internship positions available and post their CVs/resumes for employers to view. Post your CV today!

EMPLOYERS have the opportunity to access CVs/resumes from interested students.

 

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp

          

  

5. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

**NEW** VALUE-BASED REIMBURSEMENT SIG

 

 Value-based Reimbursment SIG Open Meeting: Tuesday, May 17, 5:00 – 6:00 PM

Speaker: Diane L. Simison PhD, Executive Director, MEDTAP Center for Pricing & Reimbursement and Chair, Value-based Reimbursement SIG. The mission, working groups, leadership and future activities of the SIG will be presented.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/reimbursement.asp

 

CLINICAL PRACTICE SIG

 

Clinical Practice SIG Forum: Tuesday May 17 4:00– 5:00 PM, at the ISPOR 10^th Annual International Meeting.   Topic: Applying Pharmacoeconomic Principles in Clinical Practice . . . Noble Enterprise or Pipe Dream?
Moderator: Ramon Bautista MD, MBA, Department of Neurology, University of Florida HSC / Jacksonville, FL;   Speakers: F. Randy Vogenberg RPh, PhD, Senior Vice President & National Practice Council Leader, Aon Consulting, Life Sciences Consulting Practice, Providence, RI; Sara Shull MBA, PharmD, Drug Policy and Economics Pharmacist Specialist, Nebraska Health System Name, Omaha, NE;  Peter K. Wong PhD, MBA, RPh Vice President, Clinical Effectiveness & PI, Good Samaritan Hospital, Dayton, OH.

Clinical Practice SIG Workshop: Monday, May 16, 2:00 – 3:00 PM during the ISPOR 10^th Annual International Meeting. 
Topic: Standardized Reporting Format for Outcomes Research or Economic Evaluation and a System to Measure the Strength of Evidence of Studies

Speakers: Peter K. Wong PhD, MBA, RPh, Vice President, Clinical Effectiveness & PI, Good Samaritan Hospital, Dayton, OH; Alan Bakst MBA, PharmD, Director, Health Economics and Outcomes Research, TAP Pharmaceutical Products Inc, Chicago, IL; Alan Mutnick PharmD, Assistant Director Clinical Practice, University of Virginia Health System, Charlottesville, VA.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/cp.asp

 

HEALTH TECHNOLOGY ASSESSMENT SIG

 

HTA SIG Chair, Frank Papatheofanis MD, MPH, PhD, Director of the Advanced Medical Technology Assessment & Policy Program and Associate Professor of Radiology and Economics University of California at San Diego, is holding an Health Technology Assessment SIG Open Meeting on Monday, May 16 at 5:30 PM during the ISPOR 10^th Annual International Meeting for all interested members to discuss the SIG's future plans and working group leadership. Open to all meeting participants.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/hta.asp

 

PATIENT REGISTRY SIG

 

Patient Registry SIG Forum, Monday, May 17, 4:30 – 5:30 PM, at the ISPOR 10^th Annual International Meeting. Topic: Patient Registries: Opportunity and Responsibility

Moderator: Jeffrey Trotter MM, President, Ovation Research Group, Highland Park, IL Speakers: Melva T. Covington MPH, MBA, PhD, Team Leader, Global Health Outcomes
Eli Lilly and Company, Indianapolis, IN; Mohan Bala PhD, Director, Outcomes Research
Centocor, Inc, Malvern, PA: Peter Malamis MBA, Vice-President & General Manager, Post-Marketing Business Unit, Scirex, Horsham, PA; Hugh Levaux PhD, CEO, Ninaza, San Mateo, CA; Leanne Larson MHA, Vice President, Strategy & Development, Ovation Research Group, Highland Park, IL

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/patient_registr.asp

 

QUALITY OF LIFE SIG

 

Quality of Life SIG Forum: Tuesday, May 17, 4:00 – 5:00 PM

Health Status and Patient Reported Outcomes/Quality of Life Measures in the ‘Real World', Moderator: Pennifer Erickson PhD, O.L.G.A. Benefits of Using ‘Real World' Quality of Life/Patient Reported Outcomes, Speaker: Mary Cifaldi RPh, PhD Abbott Laboratories; Challenges and Limitations of ‘Real World' Quality of Life/Patient Reported Outcomes, Speaker: Richard Chapman PhD, ValueMedics Research;  

Methods and Best Practices for ‘Real World' Quality of Life/Patient Reported Outcomes Studies, Speaker: Jamie Banks MS, Cambridge Outcomes; Next Steps for ISPOR

Speaker: Andreas Pleil PhD, Pfizer Incorporated.

 

Quality of Life SIG Open Meeting: Tuesday, May 17 5:00 – 6:00 PM

Speaker: Judith Barr PhD, Associate Professor, Northeastern University & Director, National Education and Research Center for Outcomes Assessment, Boston, MA, USA.

The mission, working groups, leadership and future activities of the SIG will be presented. Open to all meeting participants.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/qol.asp

 

MEDICATION COMPLIANCE SIG

    

Two workshops will be presented at the ISPOR 10^th International Meeting, May 15-18^th, 2005:

Methods for Medication Compliance Studies: An Overview of the ISPOR Medication Compliance SIG Guidelines, Monday, May 16, 2005, at 2:00PM – 3:00PM; and

Methods for Medication Compliance Studies: The Importance of Statistical Distributions, Tuesday, May 17, 2005, at 1:30PM – 2:30PM

  

The Medication Compliance SIG will be holding a Forum at the ISPOR 10^th Annual International Meeting, for Monday, May 16^th at 4:30pm – 5:30pm.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/medication.asp

 

RETROSPECTIVE DATABASE SIG

ISPOR Retrospective Database SIG Forum: Tuesday, May 17, 4:00 – 5:00 PM.

International Inventory of Databases for Pharmacoeconomics and Outcomes Research

Speaker:  Carl Asche PhD, University of Utah & Gordon Cummins MS, HealthCore, Inc.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/retrospective_db.asp

 

RISK MANAGEMENT SIG

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/rm.asp

 

MANAGED CARE SIG

 

For more details, please visit: http://www.ispor.org/sigs/mc_pbm.asp

 

Special Interest Group membership is open to ALL ISPOR members. To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm

 

 

6. ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES

Top

           

AWARD COMMITTEE ACTIVITIES

 

**NEW** 2005 ISPOR AVEDIS DONABEDIAN OUTCOMES RESEARCH LIFETIME ACHIEVEMENT AWARD RECIPIENT

 

The recipient of this year’s award is Katherine N. Lohr, PhD, MPhil, MA of RTI International, Durham NC, USA. 

 

**NEW** 2005 ISPOR BERNIE O’BRIEN NEW INVESTIGATOR AWARD RECIPIENT

 

The first recipient of this new annual ISPOR award is Shelby D. Reed, PhD, RPh, of Duke Clinical Research Institute, Raleigh, NC, USA.

 

**NEW** 2005 ISPOR RESEARCH EXCELLENCE AWARD RECIPIENTS

 

The recipient of the 2005 ISPOR Research Excellence Award for Methodology Excellence is Joshua Salomon PhD, Assistant Professor of International Health, Harvard Center for Population and Development Studies, Cambridge, MA, USA, for his paper, “A Multi-Method Approach to Measuring Health-State Valuations.” Health Econ 2004;13:281-90.

 

The recipient of the 2005 ISPOR Research Excellence Award for Practice Application Excellence is Sebastian Schneeweiss MD, ScD, Assistant Professor of Medicine and Epidemiology, Harvard Medical School and Harvard School of Public Health, Boston, MA, USA, for his paper, “Clinical and Economic Consequences of a Formulary Restriction of Nebulized Respiratory Drugs in Adults: Direct Comparison of Randomized and Observational Evaluations.” Br Med J  2004;328:560-4.

 

The recipients of these and other ISPOR Awards will be presented their award at the ISPOR 10^th Annual International Meeting in Washington, DC on May 17, 2005.

 

For more details, please visit: http://www.ispor.org/awards/index_.asp

 

ISPOR TASK FORCE: USING "REAL WORLD" DATA IN COVERAGE AND REIMBURSEMENT DECISIONS

 

**NEW** Co-Chair:  Lou Garrison PhD, Chair of the Economic Outcomes Working Group, University of Washington, Dept. of Pharmacy, has accepted position as Co-Chair for the

 

The Real World Task Force Working Groups (Evidence Hierarchy, Clinical Outcomes, Economic Outcomes, and Patient Reported Outcomes) continue to put forth great efforts in their mission to: 1) identify the issues (related to using and interpreting "real world" data); 2) develop a best practices document (a white paper) with a collaborative submission to Value in Health tentatively scheduled for July 2005; and 3) develop an action plan for outreach and communication. 

 

For more details, including a draft outline of this final paper, and a list of core group members, go to: http://www.ispor.org/workpaper/real_world_data.asp

 

NOMINATIONS COMMITTEE

 

2005 ISPOR Board of Directors Candidates

 

The International Society for Pharmacoeconomics and Outcomes Research is a member-driven organization.  Your participation is critical.  The activities of the organization are response to member needs.  As a member-driven organization, its governance is determined by the membership.

 

The 2005 ISPOR Board of Directors candidate’s biographical summary and ISPOR Vision statements can be found at http://www.ispor.org/members/elections/cand2005.asp:

 

President-Elect

Michael Drummond DPhil

Claude Le Pen PhD

 

Director (Position 1)

Anita Burrell MA, MBA

Scott D. Ramsey MD, PhD

 

Director (Position 2)

Joyce A. Cramer

Jenifer Ehreth PhD

 

ELECTION ENDS APRIL 15, 2005.

7. HOT TOPICS

Top

 

Keep checking back to the ISPOR eBulletin for Hot Topics next month!

 

 

8. IMPORTANT DATES TO REMEMBER

Top

 

April 19, 2005 – Early Meeting registration and hotel reservation deadline for the ISPOR 10th Annual International Meeting, Marriott Wardman Park Hotel, Washington, DC.

 

May 15-18, 2005 – ISPOR 10th Annual International Meeting, Marriott Wardman Park Hotel, Washington, DC.

 

June 20, 2005 – Abstract Submission deadline for the ISPOR 8th Annual European Congress.

 

1 July 2005 – Abstract Submission begins for the ISPOR 2^nd Asia-Pacific Congress.

 

9. ASIA CONSORTIUM AND LOCAL CHAPTER NEWS

Top

 

ISPOR ASIA CONSORTIUM

For more details on this consortium, please visit:

http://www.ispor.org/consortiums/asia.asp

 

**NEW** ISPOR 2ND ASIA-PACIFIC CONFERENCE The ISPOR 2nd Asia-Pacific Conference will be held in Shanghai, China, 5-7 March 2006. Abstract submission begins 1 July 2005 and ends 3 October 2005.  Early registration deadline is 5 February 2006.

 

**NEW** TAIWAN CHAPTER IS NEW ISPOR LOCAL CHAPTER For more details on ISPOR local chapters, please visit:

 http://www.ispor.org/local_chapters/index.asp

 

10. EMPLOYMENT

Top

**NEW** 17 NEW POSITIONS AT THE ISPOR WEBSITE: http://www.ispor.org/employment/employment_index.asp

 

Advertise your positions on ISPOR Website (~1 million hits per month)

 

**NEW** Director, Program for Assessment of Technology in Health (PATH) Position Available at McMaster University

 

 

 

 

 

 

Director, Program for Assessment of Technology in Health (PATH)

 

Department of Clinical Epidemiology & Biostatistics (CE&B), Faculty of Health Sciences, McMaster University and St. Joseph’s Healthcare Hamilton.

 

We require a dynamic leader in health technology assessment to direct the Program for Assessment of Technology in Health (PATH).  This will be an exciting opportunity to be part of the further growth in health economics and applied health services and policy research at McMaster University.  This is a university position at the Associate Professor or Professor rank (Special Appointment).  PATH, a young and highly innovative research program, is funded in part by a $3 million grant from the Ontario Ministry of Health and Long Term Care in partnership with McMaster University and St. Joseph’s Healthcare, Hamilton.

 

PATH researchers play a key role in the economic evaluation of new and existing health technologies that informs insurance coverage reimbursement decision-making in Ontario and elsewhere.  PATH investigators collaborate with colleagues from several McMaster research centres and programs including the Centre for Evaluation of Medicines (CEM), the Centre for Health Economics and Policy Analysis (CHEPA), Evidence-based Practice Centre (EBPC), the Program in Policy Decision-Making (PPD), the Health Information Research Unit (HIRU), St. Joseph’s Health System Research Network, and the Program in Evidence-Based Care at Cancer Care Ontario’s Hamilton site.

 

Qualifications include a PhD or equivalent in Health Economics or Decision Sciences. You should have an international reputation in health services research and health technology assessment based on a strong record of success in securing peer-reviewed funding and a track record of significant publications in relevant scholarly journals.  Successful collaboration with government agencies and industries will be regarded favorably.

 

In addition to directing PATH and leading future growth and development, you will undertake research, education, administration and service activities.  In particular, you will teach in the multi-disciplinary Health Research Methodology MSc/PhD program and/or the rapidly growing Bachelor of Health Sciences program, with opportunities to teach in other educational programs at McMaster.

 

The University has identified health services and policy research as a strategic priority area, which may provide the successful applicant with future leadership opportunities at even more senior levels.  Of particular note is the possibility of a combined Directorship for PATH and CHEPA for a suitably qualified candidate.

 

McMaster is also home to one of the largest international concentrations of health economists including 20 health economic investigators with a track record of highly productive and collegial collaboration.  Several of the investigators are in the Department of Economics, which maintains both a research and education specialization in health economics.  The successful candidate would be eligible for associate membership in the Department of Economics.

 

For more information about the various areas of interest, visit: www.fhs.mcmaster.ca/ceb (Clinical Epidemiology & Biostatistics), www.thecem.net (Centre for Evaluation of Medicines), www.chepa.org (The Centre for Health Economics and Policy Analysis), http://hiru.mcmaster.ca/index.htm (Health Information Research Unit), www.researchtopolicy.ca (Program in Policy Decision-Making), http://hiru.mcmaster.ca/epc/ (Evidence-Based Practice Centre), www.cancercare.on.ca/access_PEBC.htm (Program in Evidence-Based Care), www.fhs.mcmaster.ca (The Faculty of Health Sciences), and www.stjosham.on.ca (St. Joseph’s Healthcare).

 

Applicants are invited to submit a cover letter of application, Curriculum Vitae, and contact details for three referees to:  R. Brian Haynes, MD, PhD, Chair, Department of Clinical Epidemiology & Biostatistics, Faculty of Health Sciences, 1200 Main St. West, Hamilton, Ontario  L8N 3Z5 Canada.  Tel: 905-525-9140, ext. 24931; email: bhaynes@mcmaster.ca

 

INTERNSHIPS

Visit ISPOR's Internship-Professional Recruitment Assistance Program (I-PRAP) at http://www.ispor.org/iprap/index.asp

 

STUDENTS: Post your CVs/resumes for employers to view and search for internship positions available.  Nine student resumes posted! 

 

EMPLOYERS: Post your Intern positions for FREE and access CVs/resumes from students.

 

If you have any questions, please contact: iprap@ispor.org.

 

 

11. ISPOR MEMBERSHIP

Top

 

Update your email address at https://www.ispor.org/members/addresschange.asp! Your email address is required as part of your log in information in the members only section of the ISPOR website.